Preparation and characterization of Keratin-PEG conjugate-based micelles as a tumor microenvironment-responsive drug delivery system
Source abstract
Abstract
Keratin-based drug carriers have attracted great interest due to their intrinsic biocompatibility and tumor micro-environmental responsiveness. In the study, keratin was first extracted from human hair with reduction method. The reduced keratin was successively conjugated with poly(ethylene glycol) (PEG) via thiol Michael addition reaction and iodoacetic acid (IAA) via substitution reaction to impart both physical stability and acidity responsiveness. Subsequently, the conjugated keratin was fabricated into micelles and loaded with doxorubicin (DOX) by self-assembly. The micelles exhibited pH, glutathione (GSH) and enzyme (trypsin) triple-responsiveness as well as charge reversibility under the simulated tumor microenvironment. These drug-loaded micelles exhibited high toxicity against A549 cells with low side effect on normal cells. Furthermore, anticancer efficacy in vivo revealed DOX-loaded micelles presented higher therapeutic efficiency than free DOX. Moreover, these micelles were stable under physiological conditions, and could be internalized through endocytosis without hemolysis. Based on the results, the drug-loaded micelles were satisfactory candidates for drug carriers.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Dyeing and Modifying Textile Fibers · Nonlinear Optical Materials Studies · Biocrusts and Microbial Ecology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, Jiangsu Key Laboratory of Bio-functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, P. R. China;
Laboratory of Controllable Preparation and Application of Nanomaterials, Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, P. R. China
References (48)
Show source-provided references
1. 10.1016/j.addr.2007.08.04410.1016/j.addr.2007.08.044 ↗
2. 10.1016/j.addr.2012.01.02010.1016/j.addr.2012.01.020 ↗
3. 10.1039/c2cs15327k10.1039/c2cs15327k ↗
4. 10.1016/j.addr.2013.09.00810.1016/j.addr.2013.09.008 ↗
5. 10.1016/j.ijpharm.2017.11.00310.1016/j.ijpharm.2017.11.003 ↗
6. 10.1021/acs.chemrev.8b0019910.1021/acs.chemrev.8b00199 ↗
7. 10.1016/S0169-409X(02)00226-010.1016/S0169-409X(02)00226-0 ↗
8. 10.1021/ja803688x10.1021/ja803688x ↗
9. 10.1002/anie.20090267210.1002/anie.200902672 ↗
10. 10.1039/b904746h10.1039/b904746h ↗
11. 10.1016/j.ijpharm.2018.08.01910.1016/j.ijpharm.2018.08.019 ↗
12. 10.1016/S0168-3659(99)00194-710.1016/S0168-3659(99)00194-7 ↗
13. 10.1016/j.biomaterials.2008.12.01310.1016/j.biomaterials.2008.12.013 ↗
14. 10.1016/j.biomaterials.2011.07.03210.1016/j.biomaterials.2011.07.032 ↗
15. 10.1016/j.jconrel.2003.12.02110.1016/j.jconrel.2003.12.021 ↗
16. 10.1016/j.biomaterials.2011.06.06410.1016/j.biomaterials.2011.06.064 ↗
17. 10.1080/1061186080245582110.1080/10611860802455821 ↗
18. 10.1016/j.polymer.2015.04.07010.1016/j.polymer.2015.04.070 ↗
19. 10.1039/C7PY00443E10.1039/C7PY00443E ↗
20. 10.3390/ma302099910.3390/ma3020999 ↗
21. 10.1039/C7BM00411G10.1039/C7BM00411G ↗
22. 10.1002/pi.246310.1002/pi.2463 ↗
23. 10.1039/C5RA16253J10.1039/C5RA16253J ↗
24. 10.1002/term.165310.1002/term.1653 ↗
25. 10.1016/j.matlet.2016.04.03610.1016/j.matlet.2016.04.036 ↗
26. 10.1016/j.msec.2016.12.06710.1016/j.msec.2016.12.067 ↗
27. 10.1016/j.msec.2018.05.07310.1016/j.msec.2018.05.073 ↗
28. 10.1039/c2jm34136k10.1039/c2jm34136k ↗
29. 10.1021/am405060x10.1021/am405060x ↗
30. 10.1016/j.ijbiomac.2015.03.05110.1016/j.ijbiomac.2015.03.051 ↗
31. 10.1016/j.ijbiomac.2014.06.02510.1016/j.ijbiomac.2014.06.025 ↗
32. 10.1016/j.ijbiomac.2018.11.17810.1016/j.ijbiomac.2018.11.178 ↗
33. 10.1021/acs.bioconjchem.5b0028910.1021/acs.bioconjchem.5b00289 ↗
34. 10.1039/b502547h10.1039/b502547h ↗
35. 10.1016/j.ijpharm.2016.10.01310.1016/j.ijpharm.2016.10.013 ↗
36. 10.1007/s00216-002-1347-210.1007/s00216-002-1347-2 ↗
37. 10.1016/j.biomaterials.2018.02.02210.1016/j.biomaterials.2018.02.022 ↗
38. 10.1016/j.colsurfb.2016.02.02510.1016/j.colsurfb.2016.02.025 ↗
39. 10.1002/mabi.20140035610.1002/mabi.201400356 ↗
40. 10.1016/j.ijpharm.2010.05.00110.1016/j.ijpharm.2010.05.001 ↗
41. 10.1016/0304-3835(94)90191-010.1016/0304-3835(94)90191-0 ↗
42. Kuppusamy P · Cancer Res · 2002 · 62 · 307
43. 10.1002/path.127710.1002/path.1277 ↗
44. 10.1016/j.actbio.2015.01.03910.1016/j.actbio.2015.01.039 ↗
45. 10.1002/anie.20100296910.1002/anie.201002969 ↗
46. 10.1039/C6RA01885H10.1039/C6RA01885H ↗
47. 10.1016/j.biomaterials.2011.05.02410.1016/j.biomaterials.2011.05.024 ↗
48. 10.1016/j.jconrel.2014.10.02410.1016/j.jconrel.2014.10.024 ↗